88 devices · GMDN 56952
CD19 cell marker in-vitro diagnostic (IVD) antibodies are laboratory reagents designed to identify and measure CD19 proteins in biological samples, such as blood or tissue. Clinically, they help diagnose, monitor, or research conditions involving B-cell malignancies, immune disorders, or other pathologies where CD19 expression is relevant.
These devices are typically regulated as IVDs, often requiring validation for accuracy and performance in clinical settings. They may be supplied as kits, conjugates, or standalone antibodies, depending on their intended use—whether for research, diagnostics, or therapeutic monitoring. Classification varies by jurisdiction and intended use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.